Methods and materials for biosynthesis of mogroside compounds

US10662458B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10662458-B2
Application numberUS-201815900557-A
CountryUS
Kind codeB2
Filing dateFeb 20, 2018
Priority dateDec 4, 2012
Publication dateMay 26, 2020
Grant dateMay 26, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention relates to methods for producing mogrosides with the aid of enzymes. In particular the invention proposes various biosynthetic pathways useful for mogroside production and enzymes useful for mogroside production are provided. Furthermore, the invention provides recombinant hosts useful in performing the methods of the invention.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method of producing a mogrol precursor, a mogroside precursor, and/or a mogroside compound in a recombinant host cell, comprising: (a) a gene encoding a polypeptide capable of catalyzing conversion of oxido-squalene to produce cucurbitadienol; wherein the polypeptide comprises a polypeptide having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:1; (b) a gene encoding a polypeptide capable of catalyzing conversion of dioxido-squalene to produce 24,25 epoxy cucurbitadienol; wherein the polypeptide comprises a polypeptide having at least 90% sequence identity to the amino acid sequence set forth in SEQ ID NO:1; (c) a gene encoding a polypeptide capable of catalyzing hydroxylation of cucurbitadienol to produce 11-hydroxy-cucurbitadienol; wherein the polypeptide comprises a polypeptide having at least 90% sequence identity to the amino acid sequence encoded by a nucleotide sequence set forth in SEQ ID NO:14; (d) a gene encoding a polypeptide capable of catalyzing conversion of 11-hydroxy-cucurbitadienol to produce mogrol; wherein the polypeptide comprises a polypeptide having at least 90% sequence identity to the amino acid sequence encoded by a nucleotide sequence set forth in SEQ ID NO:5; (e) a gene encoding a polypeptide capable of catalyzing epoxidation of 11-hydroxy-cucurbitadienol to produce 11-hydroxy-24,25 epoxy cucurbitadienol; wherein the polypeptide comprises a polypeptide having at least 90% sequence identity to the amino acid sequence encoded by a nucleotide sequence set forth in SEQ ID NO:5; (f) a gene encoding a polypeptide capable of catalyzing conversion of 11-hydroxy-24,25 epoxy cucurbitadienol to produce mogrol; wherein the polypeptide comprises a polypeptide having at least 90% sequence identity to the amino acid sequence encoded by a nucleotide sequence set forth in SEQ ID NO:5; (g) a gene encoding a polypeptide capable of catalyzing epoxidation of cucurbitadienol to produce 24,25 epoxy cucurbitadienol; wherein the polypeptide comprises a polypeptide having at least 90% sequence identity to the amino acid sequence encoded by a nucleotide sequence set forth in SEQ ID NO:5; (h) a gene encoding a polypeptide capable of catalyzing hydroxylation of 24,25 epoxy cucurbitadienol to produce 11-hydroxy-24,25 epoxy cucurbitadienol; wherein the polypeptide comprises a polypeptide having at least 90% sequence identity to the amino acid sequence encoded by a nucleotide sequence set forth in SEQ ID NO:14; and/or (i) a gene encoding a polypeptide capable of beta-1,6-glycosylation of the C2′ position of the 24-O-glucose and/or beta-1,2-glycosylation of the C6′ position of the 3-O-glucose and/or the 24-O-glucose of the glycosylated mogroside compound; wherein the one or more polypeptides comprises a polypeptide having at least 90% sequence identity to the amino acid sequence encoded by the nucleotide sequence set forth in SEQ ID NO:26; wherein at least one of the genes is a recombinant gene; comprising growing the recombinant host cell in a culture medium, under conditions in which the genes are expressed; and thereby producing the mogrol precursor, the mogroside precursor, and/or the mogroside compound in the recombinant host cell. 2. The method of claim 1 , wherein the recombinant host cell comprises genes recited in items (a), (c), (d), and (i). 3. The method of claim 1 , wherein the recombinant host cell comprises genes recited in items (a), (c), (e), (f), and (i). 4. The method of claim 1 , wherein the recombinant host cell comprises genes recited in items (a), (g), (h), (f), and (i). 5. The method of claim 1 , wherein the recombinant host cell comprises genes recited in items (c), (d), and (i). 6. The method of claim 1 , wherein the recombinant host cell comprises genes recited in items (b), (f), (h), and (i). 7. The method of claim 1 , wherein the recombinant host cell comprises genes recited in items (f), (h), and (i). 8. The method of claim 1 , wherein the recombinant host cell comprises genes recited in item (i). 9. The method of claim 1 , further comprising isolating the produced mogrol precursor, the mogroside precursor, and/or the mogroside compound. 10. The method of claim 1 , wherein the mogrol precursor is oxidosqualene. 11. The method of claim 1 , wherein the mogroside precursor is a tri-glycosylated mogrol. 12. The method of claim 1 , wherein the mogroside compound is a mogroside compound di-glycosylated at C3′ position and tri-glycosylated at C24′. 13. The method of claim 12 , wherein the mogroside compound di-glycosylated at C3′ position and tri-glycosylated at C24′ position is mogroside V. 14. An in vivo method for transferring a sugar moiety to a mogrol, a glycosylated mogroside compound, or both the mogrol and the glycosylated mogroside compound, comprising contacting the mogrol, the glycosylated mogroside compound, or both the mogrol and the glycosylated mogroside compound with one or more recombinant polypeptides capable of beta 1,6-glycosylation of the C2′ position of the 24-O-glucose and/or beta-1,2-glycosylation of the C6′ position of the 3-O-glucose and/or the 24-O-glucose of the glycosylated mogroside compound and one or more UDP-sugars, under suitable reaction conditions for the transfer of one or more sugar moieties from the one or more UDP-sugars to the mogrol, the glycosylated mogroside compound, or both the mogrol and the glycosylated mogroside compound; the method comprising growing a recombinant host cell comprising a gene encoding a polypeptide capable of beta-1,6-glycosylation of the C2′ position of the 24-O-glucose and/or beta-1,2-glycosylation of the C6′ position of the 3-O-glucose and/or the 24-O-glucose of the glycosylated mogroside compound; wherein the one or more polypeptides comprises a polypeptide having at least 90% sequence identity to the amino acid sequence encoded by the nucleotide sequence set forth in SEQ ID NO:26; wherein at least one of the genes is a recombinant gene, under conditions in which one or more of the genes are expressed; wherein contacting the mogrol, the mogroside compound glycosylated at C3′ position and tri-glycosylated at C24′ position with the polypeptide comprises contacting the mogroside compound glycosylated at C3′ position and tri-glycosylated at C24′ position with the polypeptide produced by the recombinant host cell; wherein the recombinant host cell is a microorganism that is a plant cell, a mammalian cell, an insect cell, a fungal cell, an algal cell, or a bacterial cell; and wherein a mogroside compound is produced in a cell culture broth upon transfer of the sugar moiety. 15. The method of claim 14 , wherein the UDP-sugar is UDP-glucose, and the mogroside compound di-glycosylated at C3′ position and tri-glycosylated at C24′ position is produced upon transfer of the glucose moiety to the C6′ position of the 3-0-glucose of the mogroside compound glycosylated at C3′ position and tri-glycosylated at C24′ position. 16. The method of claim 14 , wherein the one or more UDP-sugar comprises UDP-glucose. 17. The method of claim 14 , wherein the mogrol is a plant-derived mogrol. 18. A method of producing a mogrol precursor, a mogroside precursor, and/or a mogroside compound, comprising whole cell bioconversion of a plant-derived or a synthetic mogrol precursor or a mogroside precursor in a cell culture medium of a recombinant host cell comprising: (a) a gene encoding a polypeptide capable of catalyzing conversion of oxido-squalene to produce cucurbitadienol; wherein the polypeptide

Assignees

Inventors

Classifications

  • Cucurbitadienol synthase (5.4.99.33) · CPC title

  • Isomerases (5.) · CPC title

  • C12P19/18Primary

    produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins · CPC title

  • Preparation of steroids · CPC title

  • Hydrolases acting on ether bonds (3.3) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10662458B2 cover?
The invention relates to methods for producing mogrosides with the aid of enzymes. In particular the invention proposes various biosynthetic pathways useful for mogroside production and enzymes useful for mogroside production are provided. Furthermore, the invention provides recombinant hosts useful in performing the methods of the invention.
Who is the assignee on this patent?
Evolva Sa
What technology area does this patent fall under?
Primary CPC classification C12P19/18. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue May 26 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).